Industry News

Low-dose molecular breast imaging effective in supplemental cancer screenings
 

Cancer detection success rates in women with mammographically dense breasts can be significantly improved through molecular imaging techniques, even using a reduced radiation dose, according to a study published in the February issue of theAmerican Journal of Roentgenology .

 
 

 

 

Adding MBI to mammography finds more cancers in dense tissue
 

Adding molecular breast imaging (MBI) to conventional mammography finds more cancers in women with dense breast tissue -- and at acceptable radiation doses for screening, according to a new study published in theAmerican Journal of Roentgenology.

 

 

 

 

 
 

 

Low-dose MBI as effective as mammo in screening dense breasts
 

Low-dose molecular breast imaging (MBI) can outperform screening mammography to detect cancer in women with dense breasts, according to a study presented on Tuesday at the annual RSNA meeting.

 

Researchers from the Mayo Clinic in Rochester, MN, used an 8-mCi dose of technetium-99m (Tc-99m) sestamibi rather than 20 mCi in MBI exams on more than 1,600 women with dense breasts. MBI still detected more cancers than mammograms, the group found.